<DOC>
	<DOCNO>NCT00626834</DOCNO>
	<brief_summary>This Phase 1 safety/tolerably study determine clinically significant interaction oral vigabatrin ( gamma vinyl-gamma-amino butyric acid ; VGB ) concurrent intravenous ( IV ) cocaine infusion .</brief_summary>
	<brief_title>Vigabatrin Ph 1 Cocaine Interaction Study</brief_title>
	<detailed_description>STUDY DESIGN : This randomize , double-blind , placebo-controlled , parallel group study effect VGB compare placebo control physiological subjective effect IV infusion cocaine ( cocaine experience volunteer ) . Subjects randomize within clinical site one four group ( placebo control one three dos VGB twice daily ) .During VGB steady state dosing , subject receive double-blind infusion saline cocaine . Subjects ask return follow-up approximately 7 14 day day clinic discharge . STUDY DURATION : The maximum duration 56 day , include 14 inpatient day assessment investigational product administration , two follow-up visit clinic discharge . SAMPLE SIZE : Twenty-four subject randomize one three dos vigabatrin placebo . POPULATION : Volunteer , cocaine-experienced , non-treatment seek cocaine user , 18 45 year age .</detailed_description>
	<mesh_term>Behavior , Addictive</mesh_term>
	<mesh_term>Cocaine-Related Disorders</mesh_term>
	<mesh_term>Vigabatrin</mesh_term>
	<mesh_term>Cocaine</mesh_term>
	<mesh_term>Central Nervous System Stimulants</mesh_term>
	<criteria>Be 18 45 year age , inclusive Currently nontreatment seek cocaine user confirm positive urine test cocaine Able provide write informed consent A negative pregnancy test within 72 hour prior receive first infusion cocaine Please contact site information .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>August 2016</verification_date>
	<keyword>cocaine addiction</keyword>
	<keyword>vigabatrin</keyword>
	<keyword>ovation pharmaceutical</keyword>
	<keyword>cocaine</keyword>
	<keyword>cocaine relate disorder</keyword>
	<keyword>behavior addictive</keyword>
	<keyword>mental disorder</keyword>
	<keyword>therapeutic us</keyword>
	<keyword>physiologic effect drug</keyword>
	<keyword>disorder environmental origin</keyword>
	<keyword>central nervous system stimulant</keyword>
	<keyword>central nervous system agent</keyword>
	<keyword>pharmacological action</keyword>
	<keyword>substance relate disorder</keyword>
</DOC>